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Circadian coordination of ATP 
release in the urothelium via 
connexin43 hemichannels
Atsushi Sengiku1, Masakatsu Ueda1, Jin Kono1, Takeshi Sano1, Nobuyuki Nishikawa2, 
Sumihiro Kunisue3, Kojiro Tsujihana3,4, Louis S. Liou5, Akihiro Kanematsu6, Shigeki Shimba7, 
Masao Doi3, Hitoshi Okamura3, Osamu Ogawa1 & Hiromitsu Negoro1
Day-night changes in the storage capacity of the urinary bladder are indispensable for sound sleep. 
Connexin 43 (Cx43), a major gap junction protein, forms hemichannels as a pathway of ATP in other 
cell types, and the urinary bladder utilizes ATP as a mechanotransduction signals to modulate its 
capacity. Here, we demonstrate that the circadian clock of the urothelium regulates diurnal ATP 
release through Cx43 hemichannels. Cx43 was expressed in human and mouse urothelium, and clock 
genes oscillated in the mouse urothelium accompanied by daily cycles in the expression of Cx43 and 
extracellular ATP release into the bladder lumen. Equivalent chronological changes in Cx43 and ATP 
were observed in immortalized human urothelial cells, but these diurnal changes were lost in both 
arrhythmic Bmal1-knockout mice and in BMAL1-knockdown urothelial cells. ATP release was increased 
by Cx43 overexpression and was decreased in Cx43 knockdown or in the presence of a selective Cx43 
hemichannel blocker, which indicated that Cx43 hemichannels are considered part of the components 
regulating ATP release in the urothelium. Thus, a functional circadian rhythm exists in the urothelium, 
and coordinates Cx43 expression and function as hemichannels that provide a direct pathway of ATP 
release for mechanotransduction and signalling in the urothelium.
Humans have the ability to increase bladder capacity and decrease urine production at night-time compared with 
daytime to avoid disturbances of sleep by micturition1–3. Nocturnal enuresis in childhood and frequent nocturia 
in the elderly are common and are detrimental to the quality of life by interfering with the patients’ sleeping hab-
its4–8. Insufficient bladder capacity, excessive urine production or both at night-time are the main causes of noc-
turnal enuresis or frequent nocturia1,9,10. Therefore, clarification of the mechanism(s) of nocturnal enlargement 
of the bladder would help improve these clinical complaints.
Previously, we have reported that the circadian clock regulated connexin 43 (Cx43), a major gap junction 
protein, in mouse/rat bladder muscle cells11. Mice are nocturnal (i.e. active primarily during the night), and the 
phases of their sleep-wake cycles are inverted to those of humans. Their bladder capacity is increased during 
the sleep/light phase and decreased during the active/dark phase. Cx43 levels in the bladder and the functional 
bladder capacity showed consistent circadian oscillations in wild-type mice, and the expression level of Cx43 pro-
tein in the rat/mouse bladder was inversely correlated with functional bladder capacity. The functional bladder 
capacity was higher in heterozygous Cx43+/− mice than that in Cx43+/+ mice. However, the circadian rhythms of 
Cx43 expression level and functional bladder capacity were completely lost in Cry-null mice, which have a dys-
functional circadian clock11. The clock regulator, Rev-erbα, upregulated Cx43 transcription as a co-factor of Sp-1 
using Sp-1 cis-elements of the promoter12. However, our previous report focused on bladder muscle cells11–14, and 
the roles of other components that determine bladder capacity are still unclear.
The urothelium has prominent morphological changes, termed transitional epithelium. The urothelium is 
a stratified epithelium composed of several layers — the superficial, intermediate, and basal cell layers — that 
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change their morphology in relation to the filling state of the bladder15,16. Urothelial cells appear to be cuboidal 
when the urinary bladder is not stretched in the vacant phase, and the cells become stretched to a flattened shape 
when the bladder is filled with urine. Thus, urothelial cells stretch to accommodate increase in urine volume. The 
primary function of the urothelium is a barrier to prevent the entry of pathogens into the underlying tissues. To 
achieve this, urothelial cells are connected by tight junctions, or virtually impenetrable junctions that seal the 
cellular membranes of neighbouring cells17,18.
Urothelial cells also sense changes in stretch and/or intravesical pressure and transmit mechanotransduction 
signals to the afferent nerve by releasing various neurotransmitters19,20. Of them, ATP released to the basal side 
of the urothelium activates purinergic receptors such as P2X2 and P2X3 expressed by afferent nerves in the subu-
rothelium21–25, whereas ATP released to the luminal side activates various P2X and P2Y receptors on the urothe-
lium in an autocrine/paracrine manner to form a positive feedback loop of ATP secretion26,27. These findings 
suggest that ATP modulates bladder capacity by transmitting mechanotransduction signals.
In general, there are two pathways for cellular ATP release — vesicular and non-vesicular mechanisms. 
Vesicular ATP release involves exocytosis28 while non-vesicular ATP release might be mediated by mechanical 
stretch, activation of voltage and/or ligand-gated ion channels and receptors, mitochondrial porins, ATP binding 
cassette transporters, Pannexin1 (PANX1)27,29, Transient Receptor Potential Vanilloid4 (TRPV4)30 and PIEZO131. 
Recently, it has been reported that Cx43 forms hemichannels in the pathway for non-vesicular ATP release in 
bone cells and astrocytes32,33.
Based on the above, we hypothesized that the increased functional bladder capacity during sleep-time at 
night was promoted by the decrease of mechanotransduction signalling by ATP through C43 hemichannels in 
the urothelium via the functional circadian clock. Here, we investigated the circadian role of the urothelium for 
ATP release through regulating Cx43 expression and the function of hemichannels in urothelial cells in mice and 
humans.
Results
Cx43 is expressed in human and mouse urothelium. We determined whether Cx43 is expressed in the 
human urothelium by immunostaining and reverse transcriptional polymerase chain reaction (RT-PCR) of Cx43 
in non-pathological human bladder tissue. The normal human urothelium showed positive staining for Cx43 
(Fig. 1a,b). Within the urothelium, basal cells strongly expressed Cx43 as reported in rats34, and umbrella and 
intermediate cells mildly expressed Cx43 with a scattered staining pattern. RT-PCR demonstrated the expression 
of Cx43 in the urothelium (Fig. 1c). These results confirmed normal human urothelium contains Cx43 expression.
We also examined whether Cx43 is expressed in the mouse urothelium. We performed immunostaining and 
detected Cx43 expression in normal mouse urothelium (Fig. 1d,e). In addition, we conducted layer-specific dis-
section (Supplementary Fig. S1a) and found considerable Cx43 mRNA expression in the urothelium by real-time 
quantitative RT-PCR analysis. Immunoblot analysis with layer-specific samples further confirmed the presence of 
Cx43 in the urothelium (Supplementary Fig. S1b). These findings demonstrate that Cx43 is expressed in human 
and mouse urothelium.
Mice urothelium contains an endogenous circadian clock and Cx43 oscillation. Because the dis-
tribution and expression of Cx43 are similar in humans and mice, we used mouse urothelium to characterize the 
circadian role of Cx43 in urothelial cells. To examine whether mouse urothelium per se has a circadian clock, we 
characterized the endogenous clock oscillation in ex vivo cultured urothelium isolated from Per2Luciferase knock-in 
(Per2::luc) gene reporter mice. We found a robust Per2::luc oscillation of at least six cycles (Fig. 2a, Supplementary 
Fig. S2) with a period of oscillation of 24.13 ± 0.07 (mean ± s.e.m.). This oscillation was not observed in Per2::luc 
Bmal1-knockout mice (Per2::luc/Bmal1−/−) (Fig. 2a). These results demonstrate that the bladder urothelium has 
an endogenous oscillatory machinery.
However, it was unknown whether these cellular oscillations of the circadian clock persisted in the bladder 
urothelium in vivo. We collected urothelium from mouse bladders at seven consecutive time points every 4 hours 
during the day (zeitgeber time (ZT) 0, 4, 8, 12, 16, 20 and 24) to elucidate whether the circadian clocks exist in 
the urothelium. RT-PCR analysis demonstrated that the major clock genes Bmal1, Per2 and Rev-erbα mRNA 
had robust diurnal rhythms, that Cx43 mRNA also had diurnal variation in the urothelium (Fig. 2b), and that 
Cx43 protein was cycled in abundance with a diurnal rhythm (Fig. 2c). Immunoblot analysis demonstrated Cx43 
peaked at the middle of the active/dark phase for mice, but was lowest at the middle of the sleep/light phase. The 
peak of Cx43 protein expression was delayed for 8–12 hrs from the peak of Cx43 mRNA expression. These results 
suggested that a post-transcriptional mechanism was required to induce the circadian rhythm of Cx43 protein 
expression from the diurnal variation of mRNA expression. These findings demonstrate that the levels of Cx43 
display diurnal rhythms in the mouse urothelium in vivo, in conjunction with its circadian regulator, Rev-erbα, as 
we reported in the bladder smooth muscle11.
ATP released into the bladder lumen undergoes daily variations in mice. We next examined 
whether ATP released from the urothelium had a diurnal variation in mice. We measured the concentration 
of ATP in the bladder lumen after bladder distention with 30 cm H2O for 10 minutes at ZT7, a resting phase for 
mice, and ZT19, an active phase (Fig. 2d). The concentration of ATP was significantly higher at ZT19 than at ZT7 
(p < 0.01), which was in accord with Cx43 expression in the urothelium in wild-type mice. However, such diurnal 
changes in ATP release and Cx43 protein expression was lost in arrhythmic Bmal1-knockout mice (Fig. 2e,f). 
These results suggest that ATP release from the urothelium induced by bladder distension undergoes daily varia-
tions regulated by the circadian clock and that changes in ATP release in the resting phase versus the active phase 
may be involved in the daily oscillation of functional bladder capacity.
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Immortalized human urothelial cells exhibit circadian cycles of Cx43 expression and ATP release. 
We found circadian profiles of the clock genes, as well as Cx43 and ATP release in the urothelium. To inves-
tigate the causal-relationship among these findings, we used hTERT-immortalized human urothelial cells 
(TRT-HU1)27,35–37.
Before examining these relationships, we investigated whether this cell line was suitable for circadian study. 
After synchronization of the circadian clock by serum shock after applying 50% FBS38, we assessed Cx43 protein 
and mRNA levels every 6 hours in individual groups for 60 hours. The major clock genes BMAL1, PER2, and 
REV-ERBα mRNA had circadian rhythms and Cx43 mRNA showed a variation in vitro similar to the urothelium 
of mice in vivo (Fig. 3a). In addition, Cx43 protein showed an overt circadian rhythm in immunoblot analysis 
(Fig. 3b). ATP release induced by rinsing with cell bathing solution showed a significantly lower concentration 
at 6 and 30 hours after serum shock compared with control at 0 hour before serum shock (Fig. 3c). This variation 
in ATP release coincided with the change of Cx43 protein expression in the human urothelial cells (Fig. 3b). The 
synchronous circadian oscillations of Cx43 expression and ATP release suggest a functional correlation between 
Cx43 and ATP.
To demonstrate that the Cx43 expression and ATP release are under the control of the circadian clock, we 
investigated the influence of BMAL1-knockdown on the circadian rhythm in urothelial cells. After the trans-
fection of five different BMAL1 shRNA plasmids (sh1-5) to TRT-HU1, BMAL1 shRNA plasmid (sh2) trans-
fected cells (sh2 TRT-HU1) had the highest efficacy in BMAL1 knockdown by real-time quantitative RT-PCR and 
immunoblotting (Fig. 3d). After serum shock, the oscillation of PER2 and REV-ERBα as well as BMAL1 mRNA 
expression became unclear in sh2 TRT-HU1 compared with that in parent TRT-HU1 (Fig. 3e, Supplementary 
Fig. S3). Accordingly, the oscillation of Cx43 protein expression was lost in sh2 TRT-HU1 (Fig. 3f). In addition, 
the circadian rhythm of mechanically induced ATP release disappeared in sh2 TRT-HU1 (Fig. 3g). Furthermore, 
to confirm whether Cx43 mRNA expression was regulated by Rev-erbα and Sp-1 in urothelial cells as in smooth 
Figure 1. Cx43 immunohistochemistry (IHC) in normal human/mouse bladder mucosa. (a) The normal 
human urothelium shows positive Cx43 staining. (b) IHC with only the secondary antibody as a negative 
control. (c) Normal human urothelium expresses Cx43 in the urothelium (U) and the suburothelium (SU) 
by RT-PCR analysis. Cytokeratin 20 (CK20) and desmin were used as urothelial and suburothelial markers, 
respectively. Normal human prostate was used as a reference. (d) Normal mouse urothelium shows positive 
Cx43 staining. (e) IHC with only the secondary antibody was used as a negative control. All scale bars indicate 
100 µm.
www.nature.com/scientificreports/
4Scientific REPORTS |  (2018) 8:1996  | DOI:10.1038/s41598-018-20379-0
muscle cells11, a Cx43 promoter-reporter assay was performed using TRT-HU1. As a result, Cx43 transcription 
was upregulated in coexistence with Rev-erbα and Sp-1 in TRT-HU1 (Supplementary Fig. S4). These results sug-
gest that the circadian clock system may regulate the oscillation of Cx43 expression and ATP release in urothelial 
cells.
ATP is released from Cx43 hemichannels in urothelial cells. To investigate whether Cx43 is one 
of the pathways of ATP release in urothelial cells, we generated Cx43 knockdown and overexpressing immor-
talized human urothelial cells by using two types of immortalized human urothelial cells — TRT-HU1 and 
TERT-NHUC39,40. As for the BMAL1-knockdown procedure, the transfection of five different Cx43 shRNA plas-
mids (sh11-15) to TRT-HU1 indicated that the shRNA14 (sh14 TRT-HU1) and sh13 (sh13 TRT-HU1) plasmids 
had the two highest efficacies (Fig. 4a, Supplementary Fig. S5). The concentration of mechanically induced ATP 
release was significantly lower in sh13 and sh14 TRT-HU1 cells compared with that in control cells (Fig. 4b). 
However, Cx43-overexpressing TERT-NHUC showed a significantly higher concentration of mechanically 
induced ATP release compared with the control cells (Fig. 4c,d, Supplementary Fig. S6). In these two Cx43 
knockdown/overexpressing cell types, mRNA expressions of BMAL1 and other candidate genes associated with 
urothelial ATP release, PANX126,27, TRPV430, PIEZO131 and Vesicular Nucleotide Transporter (VNUT)28 were not 
correlated with the increase/decrease of ATP release (Supplementary Figs S7, S8). These results suggest that ATP 
Figure 2. Oscillation of Cx43 and Clock gene expression in mouse urothelium. (a) Representative oscillation 
of bioluminescence in the urothelium obtained from Per2::luc mice from an ex vivo culture. The period of 
oscillation was 24.13 ± 0.07 (mean ± s.e.m) (n = 3). The oscillation of bioluminescence in Per2::luc/Bmal1−/− 
mice were lost completely. (b) Temporal mRNA accumulation of Bmal1, Per2, Rev-erbα and Cx43 in the 
urothelium from mice under LD condition. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. the nadir value (ZT 7 
in Bmal1, ZT 23 in Per2, ZT 15 in Rev-erbα and ZT 3 in Cx43) by one-way ANOVA with Tukey’s post hoc test 
(n = 4 for each time point). The P-values with Cosinor analysis in Bmal1, Per2, Rev-erbα and Cx43 were 0.02, 
0.002, 0.005 and 0.1 respectively. ZT; Zeitgeber time. (c) Representative temporal Cx43 protein accumulation in 
the mice urothelium under LD condition as shown by immunoblotting (Cosinor analysis, P = 0.01). Full-length 
blots are presented in Supplementary Fig. S11. (d) A schematic image and photograph of bladder distention to 
measure the concentration of ATP released into the bladder. (e) Temporal change in the concentration of ATP 
release after bladder distention. The high/low level was in accord with the Cx43 expression in the urothelium of 
mice. **P < 0.01 by Student’s t-test (n = 9), which was completely lost in Bmal1-knockout mice (n = 6).  
(f) Circadian change of Cx43 protein expression in the urothelium of wild-type mice was lost in Bmal1-
knockout mice. Full-length blots are presented in Supplementary Fig. S11. All error bars indicate s.e.m.
www.nature.com/scientificreports/
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release from urothelial cells is under the direct control of Cx43 rather than that of Bmal1 or other potential genes 
for the activation of ATP release driven by Bmal1 that are yet to be identified.
In addition, mechanically induced ATP release was significantly reduced in the presence of carbenoxolone 
(Cbx), a gap junction and hemichannel inhibitor, compared with the control cells. To clarify the role of the two 
types of Cx43 channels, we used GAP19 peptide41,42, a specific Cx43 hemichannel blocker. Mechanically induced 
ATP release was significantly lower in the presence of the GAP19 peptide than that in the presence of scram-
ble control of GAP19 peptide (Fig. 4e), while dye-transfer length indicating gap junction function was not pre-
vented in the GAP19 peptide (Supplementary Fig. S9a) different from using sh14 TRT-HU1 cells that significantly 
decreased the length (Supplementary Fig. S9b). These results suggest that urothelial cells employ Cx43 hemichan-
nel rather than Cx43 gap-junction for ATP release.
Figure 3. Oscillation of Cx43 and Clock gene expression in immortalized human urothelial cells. (a) Temporal 
variation of mRNA accumulation of clock genes and Cx43 mRNA levels in serum-shocked immortalized 
human urothelial cells (TRT-HU1). The major clock genes BMAL1, PER2, and REV-ERBα had circadian 
rhythms.*P < 0.05, **P < 0.01 and ***P < 0.001 vs. the nadir value (time 24 in BMAL1, time 18 in PER2, time 
6 in REV-ERBα and time 0 in Cx43) by one-way ANOVA with Dunnett’s post hoc test (n = 3). The P-values with 
Cosinor analysis in Bmal1, Per2, Rev-erbα and Cx43 were 0.01, 0.0001, 0.002 and 0.09, respectively.  
(b) Representative immunoblots showing temporal changes in Cx43 protein levels in serum-shocked TRT-HU1 
(Cosinor analysis, P = 0.006). Full-length blots are presented in Supplementary Fig. S12. (c) Temporal variation 
of mechanically induced ATP release in TRT-HU1 after serum-shock. **P < 0.01 and *** P < 0.001 by one-
way ANOVA with Dunnett’s post hoc test (n = 9). (d) Stable knockdown of BMAL1 in TRT-HU1 (sh1-sh5). 
**P < 0.01 vs. mock by Student’s t-test (n = 3). Full-length blots are presented in Supplementary Fig. S12. 
(e) Temporal variation of mRNA accumulation of clock genes and Cx43 mRNA levels in serum-shocked 
sh2 TRT-HU1 (TRT-HU1 BMAL1 shRNA). (f) Representative immunoblots showing disturbed temporal 
changes in Cx43 protein levels in serum-shocked BMAL1 shRNA TRT-HU1. Full-length blots are presented in 
Supplementary Fig. S12. (g) Disturbed temporal variation of mechanically induced ATP release after serum-
shocked sh2 TRT-HU1 (n = 6). All error bars indicate s.e.m.
www.nature.com/scientificreports/
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To investigate whether Cx43 hemichannels function in vivo, GAP19 peptide was used for the examination of 
ATP release by bladder distention in mice at ZT19. The concentration of ATP release was significantly lower in 
the presence of GAP19 peptide than that in the presence of GAP19 scramble peptide (Fig. 4f). Based on these 
results, Cx43 hemichannels are considered part of the components regulating ATP release in the urothelium. 
Therefore, we propose that circadian rhythm in the urothelium coordinates the diurnal change in ATP release via 
Cx43 hemichannels, which modulate functional bladder capacity (Supplementary Fig. S10).
Discussion
The fundamental adaptive advantage of the circadian clock is that it allows for predictive, rather than entirely 
reactive, homeostatic regulation of physiological functions. Diurnal change in functional bladder capacity pro-
vides an adaptive advantage to secure sound sleep as well as to function correctly for daily increases in urine pro-
duction in the arousal phase5–8. In the current study, we focused on the circadian clock function of the urothelium 
and presented evidence for the existence of Cx43 in the human and mouse urothelium, the daily rhythms of clock 
Figure 4. Mechanically induced ATP release via Cx43 hemichannels has diurnal variation. (a) Stable 
knockdown of Cx43 in TRT-HU1 (sh11-sh15). **P < 0.01 and ***P < 0.001 vs. mock by Student’s t-test 
(n = 3). Full-length blots are presented in Supplementary Fig. S13. (b) Mechanically-induced ATP release was 
decreased in both sh13 and sh14 TRT-HU1. **P < 0.01 and ***P < 0.001 by Student’s t-test (n = 9). (c) Cx43-
overexpression in TERT-NHUC (Cx43 o/e TERT-NHUC). **P < 0.01 by Student’s t-test (n = 3). Full-length 
blots are presented in Supplementary Fig. S13. (d) Increased mechanically induced ATP release in Cx43 o/e 
TERT-NHUC. ***P < 0.001 by Student’s t-test (n = 6). (e) Mechanically-induced ATP release in the presence 
of carbenoxolone and GAP19 peptide. Each reagent was used at 50 µM. **P < 0.001 by Student t-test (n = 6). 
(f) The concentration of ATP release after bladder distention in the presence of GAP19 peptide and GAP19 
scramble peptide in vivo in mice at ZT19. **P < 0.01 by Student’s t-test (n = 6). All error bars indicate s.e.m.
www.nature.com/scientificreports/
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genes and Cx43 in the mouse urothelium and immortalized human urothelial cells, and the function of Cx43 as 
a hemichannel for ATP release. Circadian clock-regulated ATP release from Cx43 might contribute in part to the 
adaptation of functional bladder capacity in daily life.
An important result in this study was the finding that the bladder urothelium has a circadian rhythm gen-
erated by the circadian clock and that this indeed modulates urothelial ATP release mechanically stimulated by 
bladder distension in a circadian manner. Diurnal variations in ATP play a crucial role in various organisms. 
In rodents, the diurnal change in extracellular ATP levels in astrocytes may provide a mechanism for the clock 
control of gliotransmission between astrocytes and neurons, which might be associated with sleep-wake changes 
in the brain by modulating energy metabolism and glial activity43,44. Clinically, the diurnal enhancement of pain 
hypersensitivity might be mediated by the clock gene controlled glucocorticoid-induced enhancement of extra-
cellular ATP release in the spinal cord45. As above, diurnal variations in ATP levels might be an important mech-
anism in nature and it is noteworthy that the physiological role of the circadian clock in the urothelium has been 
demonstrated here.
The mechanism of circadian ATP release from the urothelium was also demonstrated in this study. Cx43 
expression had a circadian rhythm in the bladder urothelium and Cx43 functioned as a hemichannel to release 
ATP in urothelial cells. In addition, the concentration of mechanically induced ATP release had oscillations that 
correlated with Cx43 expression in the urothelium. It is generally understood that urothelial cells sense the exten-
sion stimulus and release ATP, which is essential for the micturition reflex19,46. Stretch-induced urothelial ATP 
release evokes afferent nerves within the suburothelial tissues via P2X and P2Y receptors and conveys a sense 
of bladder filling to the central nervous system23–27. Considering the diurnal change of mechanically induced 
ATP release via Cx43 hemichannels in the present study and the increased functional bladder capacity in Cx43 
hetero-knockout mice11,47,48, we infer that the diurnal rhythm of micturition is regulated by diurnal changes in the 
level of perception for bladder distention.
Our study had some limitations. It was unclear how and to what extent the Cx43 hemichannels are involved in 
the pathway of ATP release. ATP is abundant in the cell cytoplasm and is released extracellularly by several mech-
anisms49,50. Our previous study of whole bladder microarray analysis demonstrated that other genes involved 
in the major pathways of ATP release including Panx1 channels did not show significant circadian change11 
(microarray data deposited in the Gene Expression Omnibus under accession code GSE35795). In addition, 
Panx1+/+ and Panx1−/− mice displayed a similar phenotype in voiding micturition pattern51. However, it was 
reported that clock genes regulate the circadian expression of several genes associated with ATP release in ex vivo 
mouse bladder mucosa52. Although our current results do not exclude the role of other genes in the circadian 
change of ATP release in the urothelium because the expression amount was also regulated at multiple levels by 
transcriptional, post-transcriptional and post-translational mechanisms53, the present study demonstrated diur-
nal ATP release in the urothelium as well as functionally associated diurnal variation in Cx43 expression.
Another limitation is that roles of the circadian clock and ATP in physiological or pathological conditions 
in humans have not been investigated yet. Urothelial ATP signalling is involved in pathological conditions such 
as overactive bladder, but the role of P2X2/3 receptors is still controversial in physiological conditions19,54,55. 
Interestingly, it was suggested that the circadian clock in the bladder is modulated by endogenous purinergic 
receptors and that dysregulation of the interaction between the clock and major endogenous receptors may have 
an effect on maintaining bladder functions56. Further studies are expected to elucidate the roles of the circadian 
clock and ATP signalling in human micturition.
Despite these limitations, our study revealed that the circadian clock in the urothelium contributes to the 
formation of diurnal changes of ATP release through the coordination of Cx43 expression, which may modulate 
day–night changes in functional bladder capacity. This novel concept has the potential to lead to a new treatment 
strategy for nocturnal enuresis in childhood and/or frequent nocturia in the elderly, which are detrimental to the 
quality of life.
In conclusion, a functional circadian rhythm exists in the urothelium, and coordinates Cx43 expression and 
function as hemichannels that provide a direct pathway of ATP release for mechanotransduction and signalling 
in the urothelium. This understanding warrants further investigation for diseases characterized as disorders of 
micturition rhythm including nocturnal enuresis and nocturia.
Methods
Animals. Five-week-old female C57BL/6 mice were purchased from CLEA Japan (Tokyo, Japan) or Japan 
SLC, Inc. (Hamamatsu, Japan). Global Bmal1-knockout C57BL/6 mice were generated by mating Probasin-Cre; 
Bmal1flx/flx mice57–59. Mice were housed at a constant room temperature with a cycle of 14 hours light (7:00 am to 
9:00 pm) and 10 hours dark (9:00 pm to 7:00 am). Food and water were available ad libitum. All animal experi-
ments were approved by the Kyoto University animal experiment committees (Permit Number: Medkyo15504), 
and all animals used in this study were treated according to the guidelines for animal experimentation of the 
experimental animal center of Kyoto University.
Immunohistochemistry of normal human and mouse bladder. Normal human bladder tissue 
was obtained from a 67-year-old female patient who underwent anterior pelvic exenteration under the diag-
nosis of urethral malignant melanoma after informed consent. Immunostaining with Cx43 antibody (C6219, 
Sigma-Aldrich, St. Louis, MO, USA) was performed with normal testis as a positive control. Normal mouse blad-
der tissue was obtained from ten-week-old female C57BL/6 mice. Immunostaining with Cx43 antibody (C6219, 
Sigma-Aldrich) was performed with normal heart as a positive control. All human experiments were performed 
in accordance with guidelines on the use of human materials in Kyoto University, and all human experiments 
were approved by the ethical committees at Kyoto University Hospital. All immunostaining was performed at the 
Center for Anatomical, Pathological and Forensic Medical Researches in Kyoto University.
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Reverse transcriptional PCR of normal human bladder. Normal human urothelium was obtained 
from a 39-year-old male patient who underwent pelvic exenteration under the diagnosis of advanced rectal can-
cer after informed consent. Normal urothelium was obtained by scraping the bladder mucosa with a scalpel, and 
the suburothelium was obtained by resection with scissors. Normal human prostate was obtained as a positive 
control from a 73-year old male patient who underwent holmium laser enucleation of the prostate (HoLEP) 
under the diagnosis of benign prostatic hyperplasia. Total RNA was extracted using an RNeasy Mini kits (Qiagen, 
Hilden, Germany) according to the manufacturer’s protocols and complementary DNA was synthesized from 
1 µg of RNA using ReverTra Ace qPCR RT Kit (TOYOBO, Osaka, Japan). The primers for PCR are shown in 
Supplementary Table S1. Reaction mixtures were denatured at 94 °C for 2 min, followed by 35 PCR cycles using 
Mastercycler nexus GSX1 (Eppendorf, Germany). Each cycle consisted of the following steps: 94 °C for 20 s, 58 °C 
for 30 s, and 72 °C for 35 s.
Bioluminescence recording. The urothelium were obtained from adult Period2Luciferase knock-in (Per2::luc) 
mice (Jackson Laboratories)60. The urothelial layer was dissected away from the smooth muscle layer using oph-
thalmology scissors and cultured with 800 µl of Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich), 
supplemented with 10 mM HEPES (pH 7.2), 2% B27 (Thermo Scientific, Rockford, IL, USA), 25 units/ml peni-
cillin, 25 mg/ml streptomycin, and 1 mM luciferin, in 35-mm dish, and air sealed. Bioluminescence was continu-
ously monitored without interruption for 7 days immediately upon placement in culture with a dish-type photon 
countable luminometer (Kronos Dio, ATTO, Tokyo, Japan) at 35 °C.
Tissue preparation. Eight-week-old female C57BL/6 mice anesthetized with isoflurane and euthanized by 
cervical dislocation, were analysed at seven consecutive time points every 4 hours during the day under a dim 
light (n = 6 for each time). The bladders were removed and sliced open in a 6-cm dish containing cold normal 
saline. We scraped the bladder mucosa with a cell scraper in cold normal saline, and collected the normal saline 
including desquamated urothelium. It was immediately cryopreserved in liquid nitrogen for protein assay, or 
mixed with RNAlater (Sigma-Aldrich) preserved at 4 °C for mRNA assay. The remaining suburothelium and 
smooth muscle layer were gathered together as a reference, and a part of the liver was used as a control.
Cell culture. The hTERT-immortalized human urothelial cell line (TRT-HU1) generated by Dr. Louis S. 
Liou was a gift from Dr. Rosalyn M. Adam (Urological Diseases Research Center, Children’s Hospital Boston, 
Boston), and hTERT-immortalized normal human urothelial cells (TERT-NHUC) were generated and kindly 
provided by Dr. MA Knowles (Cancer Research UK Clinical Centre, St James’s University Hospital, Beckett Street, 
Leeds LS97TF, UK). TRT-HU1 cells were maintained in DMEM (Sigma-Aldrich) containing 2 mM L-glutamine 
and 110 mg/L sodium pyruvate supplemented with 15% FBS (GIBCO), non-essential amino acids (GIBCO), 
and 1.15 mM 1-thioglycerol, as previously described32. TERT-NHUC cells were maintained in KSFM (Life 
Technologies Ltd, Paisley, UK) supplemented with the supplied bovine pituitary extract and epidermal growth 
factor in a humidified atmosphere of 5% CO2 at 37 °C, as previously described36.
Serum shock analysis of hTERT-cells. As previously reported38, TRT-HU1 were cultured until 
sub-confluent in DMEM with 15% FBS followed by 48 hours incubation in DMEM with 0.5% FBS. The cells 
were treated with 50% horse serum (GIBCO) in DMEM for 2 hours, and washed twice with DMEM and then 
maintained in DMEM with 0.5% of FBS for a maximum of 72 hours. The time 0 (hr) in the figures indicates before 
serum shock.
Immunostaining of hTERT-cells. After washing with TBS (3 times, 5 min), the cells were permeabi-
lized for 30 min with 0.25% Triton X-100 (in TBS), blocked for 60 min with 1% bovine serum albumin (BSA, 
in TBS) and incubated 2 days with primary antibodies (in 1% BSA + 0.4% Triton X-100) at 4 °C. The following 
primary antibodies were used: rabbit polyclonal Cx43 antibody (C6219, Sigma-Aldrich, 1:500), mouse mono-
clonal anti-vimentin antibody (ab8978, 1:100, Sigma-Aldrich). Donkey anti-mouse IgG (H + L) Alexa Fluor 488 
(ab150105, Abcam, Cambridge, UK) was used as secondary antibody followed by DAPI nuclear staining.
Real-time quantitative RT-PCR analysis. Total RNA extraction and complementary DNA synthesis 
from the mouse urothelium or cultured cells was done using the same procedure as for the human urothelium. 
Real-time quantitative RT-PCR was performed with SYBR Green PCR Master Mix (Life Technologies, Carlsbad, 
CA, USA) and a 7300 Real-time PCR system (Life Technologies). The thermal cycling conditions were 94 °C for 
15 s, 60 °C for 15 s, and 72 °C for 1 min. Values were adjusted relative to the expression levels of the housekeeping 
gene Gapdh or 18 s ribosome. Primers used are listed in Supplementary Table S1. The ΔΔCt method was used to 
determine the relative gene expression of the genes of interest.
Immunoblotting. Whole cell lysates from bladder urothelium and cultured cells were lysed with radioim-
munoprecipitation assay (RIPA) buffer containing proteinase inhibitors, which were resolved by SDS-PAGE and 
transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA) using a Mini Trans-Blot Cell 
system (Bio-Rad Laboratories). Membranes were blocked with 5% bovine serum albumin diluted in TBST (BSA/
TBST) and incubated with primary antibodies diluted in 1% BSA/TBST followed by incubation with horseradish 
peroxidase-conjugated secondary antibodies diluted in 1% BSA/TBST and developed for reading by enhanced 
chemiluminescence (SuperSignal West Pico Chemiluminescent Substrate, Thermo). Images were acquired with 
the LAS-4000 imaging system (Fujifilm Life Science, Tokyo, Japan). Anti-Cx43 (C6219, Sigma-Aldrich, 1:8000), 
anti-BMAL1 (ab93806, Abcam, 1:500), anti-beta actin (ab6276, Abcam, 1:5000) and anti-GAPDH (GAPDH, 
2118, Cell Signaling Technology, Danvers, MA, USA, 1:5000) were used as the primary antibodies.
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Cell transfection. Stable knockdown of Cx43 or BMAL1 was accomplished using shRNA. Lentivirus-based plas-
mids containing TRC2-pLKO-puro shRNA sets to human BMAL1 (SHCLNG-NM_001178; TRCN0000331011 (sh1), 
TRCN0000331012 (sh2), TRCN0000331014 (sh3), TRCN0000331078 (sh4), TRCN0000331079 (sh5) and the same 
sets to human Cx43 (SHCLNG-NM_000165; TRCN0000333535 (sh11), TRCN0000344841 (sh12), TRCN0000344842 
(sh13), TRCN0000344843 (sh14), TRCN0000353147 (sh15)) were purchased from Sigma-Aldrich. Non-silencing 
shRNAs (Sigma-Aldrich) were used as negative controls. To obtain Cx43-overexpressing urothelial cells, Precision 
LentiORF GJA1w/Stop Codon (OHS5897-202619897) and Precision LentiORF RFP Control Glycerol Stock 
(OHS5832) were purchased from Open Biosystems (Huntsville, AL, USA). The experimental procedure for transfec-
tion was performed according to the Sigma-Aldrich or Open Biosystems technical manual.
Measurement of ATP release in vivo and in vitro. After eight-week-old female C57BL/6 mice with 
or without Bmal1-knockout were anesthetized with 4% (induction) and 2% (maintenance) isoflurane, a 24 G 
catheter (SR-OT2419C, Terumo, Tokyo, Japan) was inserted into the urethra and clamped with a clip (AM-1, 
Natsume Seisakusho Co. Ltd., Tokyo, Japan), and connected to a tube filled with phosphate buffered saline (PBS). 
After bladder distention with 30 cm H2O for 10 minutes, we collected the PBS from the bladder lumen. The ATP 
concentration in the samples was calculated from standard curves constructed using ATP from 20 nM to 20 μM.
Measurement of ATP release in vitro. The luciferin-luciferase assay (CellTiter-Glo®2.0 Assay; Promega, 
Madison, WI, USA) was used to quantify the amounts of ATP released in the bathing solution of cultured cells in 
response to rinsing-induced mechanical stimulation27. Briefly, 20 μl of bathing solution samples were individually 
placed in triplicate in white walled 96-well plates (Nunc F96 MicroWell; Thermo), and 100 μl CellTiter-Glo®2.0 
reagent was added directly to each well. Plates were incubated at room temperature for 15 minutes and were 
transferred to the Multilabel Plate Reader VICTOR X5 (PerkinElmer, Waltham, MA, USA), where luminescence 
was measured using a 1-sec integration time. The ATP concentration in the samples was calculated with the same 
procedure as for the in vivo study.
Dye-transfer experiment. Dye-transfer experiment was performed with Lucifer yellow (LO259, Sigma). In 
6 cm dishes, confluently cultured cells were cut with a diamond cutter in the presence of Lucifer yellow followed 
by 4% PFA fixation. Images in fluorescence along with the cutting line were taken and the dye-transfer lengths 
from the cutting edge were measured using ImageJ software (http://rsb.info.nih.gov/ij/).
Reagents. Carbenoxolone disodium salt (CBX), GAP19 peptide (KQIEIKKFK) and GAP19 scramble peptide 
(IKFKKEIKQ) were purchased from Sigma-Aldrich.
Statistical analysis. All data are expressed as the mean ± s.e.m. JMP Pro 11 (SAS Institute Inc., Cary, NC, 
USA) was used for statistical analysis. Unpaired t-test, one-way ANOVA with Dunnett’s post hoc test, one-way 
ANOVA with Tukey’s post hoc test were performed when appropriate. The P-values of gene oscillation were cal-
culated using a free Cosinor analysis software (Version 3.1) available at http://www.circadian.org/softwar.html. 
P < 0.05 was regarded as statistically significant. In the figures, statistical significance is indicated as follows: 
*P < 0.05, **P < 0.01, and ***P < 0.001.
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